Zimbabwe has declined a significant US health deal worth 367 million US dollars (272 million pounds) over five years over Washington's request for sensitive information.
The decision became public after a government memo dated December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the deal was "lopsided".
An official spokesman has since stated that the United States was requesting genetic material for research and commercial purposes but was unwilling to guarantee the resulting advantages from any future treatments.
"We must now begin the challenging and unfortunate task of winding down our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had furnished over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for further negotiations to reach a deal acceptable to both sides so the country's vital HIV programme can proceed.
Broader Context
This rejection comes after a similar situation in neighbouring Kenya, where a court blocked a related deal with the US after concerns were filed about the security of Kenyans' health data.
After resuming the presidency last year, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
The agency had administered assistance for the American government, but Trump claimed its spending was "inefficient" and his administration was pursuing direct bilateral agreements to boost openness and accountability.
Based on statements, Sixteen nations in Africa have to date agreed to these new agreements, constituting more than $18.3bn of fresh investment.
Specifics of the Declined Deal
The funds for Zimbabwe would have gone towards "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership could have provided significant benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on HIV treatment through American-funded programmes," Tremont added.
However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".
"Zimbabwe was being asked to surrender its genetic material and health information indefinitely, with no equivalent assurance of benefiting from any medical innovations – such as new medicines or tests – that might be developed from that provided information," Mangwana explained.
"In essence, our country would provide the raw materials for medical research without any certainty that the end products would be accessible to our people if a new health crisis emerge."
National Interest and Global Health
Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of bilateral deals were disrupting frameworks already set up through the global organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework designed to deal with future pandemics.
"This system is designed to ensure that when a nation provides its data, the benefits – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the resources to develop them."
These objections regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We encourage continued dialogue with our US partners on how subsequent co-operation could be structured in a manner that respects the sovereignty and interests of both nations."
Health Experts Response
Medical experts said it recognised the official position, but recommended that negotiations need to persist given that much of the nation's Aids initiatives depended on external financing.
"If technical issues arise, including those relating to information security or implementation frameworks, these can often be addressed via detailed discussion and mutually agreed protections," the group added.
This impasse underscores the continuing tensions between receiving vital foreign assistance and safeguarding local interests in an increasingly interconnected world.